BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38708853)

  • 21. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
    Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
    Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway.
    Wu C; Chen S; Wu Z; Xue J; Zhang W; Wang S; Xindong Zhao ; Wu S
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):98. PubMed ID: 38381215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma.
    Yong X; Zhang Y; Tang H; Hu H; Song R; Wu Q
    Anticancer Drugs; 2024 May; ():. PubMed ID: 38748610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fludarabine Enhances Radiosensitivity by Promoting Ferroptosis in B-Cell Lymphoma.
    Long Q; Tao H; Wang P; Wu B; Zhu Q; Chen H; Lao G; Yang Y; Liu G; Liu S; Wu Y
    Radiat Res; 2024 Mar; 201(3):224-239. PubMed ID: 38235545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
    Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
    Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA NEAT1 regulate diffuse large B-cell lymphoma by targeting miR-495-3p/PD-L1 axis.
    Yuan J; Yang J; Wang R; Hao H; Li J
    Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):429-436. PubMed ID: 35352617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB.
    Lin D; Wang Y; Lei L; Lin C
    Autoimmunity; 2022 Mar; 55(2):127-135. PubMed ID: 35001739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL.
    Bian W; Li H; Chen Y; Yu Y; Lei G; Yang X; Li S; Chen X; Li H; Yang J; Yang C; Li Y; Zhou Y
    Biomed Pharmacother; 2024 Apr; 173():116386. PubMed ID: 38492438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
    Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
    Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway.
    Lu K; Li B; Zhang H; Xu Z; Song D; Gao L; Sun H; Li L; Wang Y; Feng Q; Chen G; Hu L; Wei R; Xie Y; Yu D; Wu X; Zhu W; Shi J
    Signal Transduct Target Ther; 2020 Apr; 5(1):31. PubMed ID: 32296013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway.
    Gu J; Wang X; Zhang L; Xiang J; Li J; Chen Z; Zhang Y; Chen J; Shen J
    BMC Complement Med Ther; 2021 Jun; 21(1):163. PubMed ID: 34088288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway.
    Li Y; Zhang PY; Yang ZW; Ma F; Li FX
    J Gene Med; 2020 Aug; 22(8):e3186. PubMed ID: 32187802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
    Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
    Front Oncol; 2021; 11():657723. PubMed ID: 34485112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.
    Li Y; Xu B; Ren X; Wang L; Xu Y; Zhao Y; Yang C; Yuan C; Li H; Tong X; Wang Y; Du J
    Cell Mol Biol Lett; 2022 Sep; 27(1):81. PubMed ID: 36180832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF.
    Zhao J; Li Z; Zhang H; Qin T; Zhao J; Pei Q
    Chem Biol Drug Des; 2024 May; 103(5):e14533. PubMed ID: 38684373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel benzoxazinone derivative YLT-LL-11 inhibits diffuse large B-cell lymphoma growth via inducing cell cycle arrest and apoptosis.
    Peng C; Sun C; Wang N; He Y; Xu J; Deng Y; Gao L; Zhong J; Xiong X; Liu L
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31527063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
    Wanner K; Hipp S; Oelsner M; Ringshausen I; Bogner C; Peschel C; Decker T
    Br J Haematol; 2006 Sep; 134(5):475-84. PubMed ID: 16856892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma.
    Wu H; Zhang J; Fu L; Wu R; Gu Z; Yin C; He K
    Technol Cancer Res Treat; 2023; 22():15330338221147772. PubMed ID: 36762399
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of Asparaginase on Diffuse Large B-Cell Lymphoma Cell Apoptosis and Its Related Mechanism].
    Gao X; Jiao J; Liu MD; Qin YY; Xu LY; Sang W; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1482-1489. PubMed ID: 31607302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.